XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations (Tables)
6 Months Ended
Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations for Consolidated Balance Sheets and Income Statements

The following statements are the unaudited condensed consolidated balance sheets and income statements for the Company’s discontinued operations:

 

   June 30, 2022   December 31, 2021 
         
ASSETS          
Current assets:          
Cash and cash equivalents  $-   $- 
Restricted cash   -    - 
Accounts receivable   -    - 
Prepaid expenses   -    - 
Total current assets  $-   $- 
           
Investments in non-consolidated entities   -    - 
Note Receivables   -    - 
Real estate, property and equipment, net   1,405,910    2,086,245 
Total long-term assets held for sale   1,405,910    2,086,245 
TOTAL ASSETS  $1,405,910   $2,086,245 
LIABILITIES          
Current liabilities:          
Accounts payable       $- 
Accrued expenses  $460,691    438,192 
Accrued interest   -    - 
Current portion of long-term debt   805,000    1,000,000 
Total current liabilities   1,265,691    1,438,192 
           
Long-term liabilities:          
Note payable   421,470    487,678 
Long-term debt, less current portion   218,617    225,169 
Total long-term liabilities held for sale   640,087    712,847 
TOTAL LIABILITIES  $1,907,778   $2,151,039 

 

 

Clearday, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

 

           
   Six Months Ended June 30, 
   2022   2021 
REVENUES        
Commercial property rental revenue  $(42,986)  $(42,359)
Total revenues, net   (42,986)   (42,359)
           
Costs and expenses          
Operating expenses   45,355    72,754 
General and administrative expenses   21,033    328,684 
Total operating expenses  $66,388   $401,438 
           
Loss from operations   (23,402)   (359,077)
           
Other/(income) expenses          
Interest expense   147,578    162,599 
Gain on disposal of assets        15,000 
Equity income from investees, net of applicable taxes        - 
Impairment expense (recovery)        (811,061)
Other (income) expenses        (357,859)
Total (income)/expense   147,578    (991,321)
           
Net loss  $(170,980)  $632,244